Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by DJDawgon Dec 14, 2021 12:55pm
583 Views
Post# 34229516

RE:Interesting perspective

RE:Interesting perspective
Hey

I'm with you guys. But I'm just pointing out that there is a mass of investors that are not getting to this stock (yet) because it has issues, hopefully more in the past. Even reading the CR results is confusing because there is optimized and non-optimized because they messed up and underdosed a bunch of patients AND removed them from the trial prematurely.

The plus side is that if they hadn't messed things up like this many of us late arrivals to this company (I'm a Summer 2020 start person, so not long holder but not newbie either) wouldn't have gotten in at a good price.

Just sharing as an interesting perspective on what a novice would see if they googled for the first time.

Good luck to all.

DJ
<< Previous
Bullboard Posts
Next >>